Tumor cell lines resistant to ALA-mediated photodynamic therapy and possible tools to target surviving cells

  • Authors:
    • Adriana Casas
    • Christian Perotti
    • Bernhard Ortel
    • Gabriela Di Venosa
    • María Saccoliti
    • Alcira Batlle
    • Tayyaba Hasan
  • View Affiliations

  • Published online on: August 1, 2006     https://doi.org/10.3892/ijo.29.2.397
  • Pages: 397-405
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We isolated and characterized cell lines resistant to aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) derived from a murine adenocarcinoma and studied cross resistance with other injuries. The most resistant clones were numbers 4 and 8, which exhibited 6.7- and 4.2-fold increase in resistance respectively. Several characteristics were altered in these clones. A 2-fold increase in cell volume, higher cell spreading, and a more fibroblastic, dendritic pattern, were the morphology features that led us to think they could have different adhesive, invasive or metastatic phenotypes. The amount of porphyrins synthesized per cell in the resistant clones was similar to the parental line but, when it was expressed per mg protein, there was a 2-fold decrease, with a higher proportion of hydrophilic porphyrins. These cells were not cross-resistant to photosensitization with Benzoporphyrin derivative and Merocyanine 540, but exhibited a slight resistance to exogenous protoporphyrin IX treatment. Both clones displayed higher protein content and increased number of mitochondria, together with a higher oxygen consumption. The distinctive features found in the resistant lines led as to think how to exploit the changes induced by PDT treatment to target surviving cells. Those hypoxic cells can be also a preferential target of bioreductive drugs and hypoxia-directed gene therapy, and would be sensitive to treatment with other photosensitizers.

Related Articles

Journal Cover

August 2006
Volume 29 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Casas A, Perotti C, Ortel B, Di Venosa G, Saccoliti M, Batlle A and Hasan T: Tumor cell lines resistant to ALA-mediated photodynamic therapy and possible tools to target surviving cells. Int J Oncol 29: 397-405, 2006
APA
Casas, A., Perotti, C., Ortel, B., Di Venosa, G., Saccoliti, M., Batlle, A., & Hasan, T. (2006). Tumor cell lines resistant to ALA-mediated photodynamic therapy and possible tools to target surviving cells. International Journal of Oncology, 29, 397-405. https://doi.org/10.3892/ijo.29.2.397
MLA
Casas, A., Perotti, C., Ortel, B., Di Venosa, G., Saccoliti, M., Batlle, A., Hasan, T."Tumor cell lines resistant to ALA-mediated photodynamic therapy and possible tools to target surviving cells". International Journal of Oncology 29.2 (2006): 397-405.
Chicago
Casas, A., Perotti, C., Ortel, B., Di Venosa, G., Saccoliti, M., Batlle, A., Hasan, T."Tumor cell lines resistant to ALA-mediated photodynamic therapy and possible tools to target surviving cells". International Journal of Oncology 29, no. 2 (2006): 397-405. https://doi.org/10.3892/ijo.29.2.397